Yuval Shafrir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yuval Shafrir has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Alex R. Paciorkowski
Department of Neurology, University of Washington, Seattle, Washington, USA
1 shared publication - Andrew Escayg
Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA
1 shared publication Armando Beharab
Department of Pediatrics A and the Section of Human Biochemical and Developmental Genetics, Beilinson Medical Center, Petah Tiqva, Sackler School of Medicine, Tel Aviv University, Israel
1 shared publicationArthur L. Prensky
Departments of Neurology and Pediatrics, Washington University School of Medicine and the Child Neurology Department, St. Louis Children's Hospital, St. Louis, Missouri, U.S.A.
1 shared publicationBruce A. Kaufman
1 shared publicationC.M. Gomez
1 shared publication
Latest Publications
- 1 August 2020
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 80, 226
Response to: Deng L, Ma A, Wood N, Ardern-Holmes S. Vaccination management in an asymptomatic child with a novel SCN1A variant and family history of status epilepticus following vaccination: A case report on a potential new direction in personalised medicine. Seizure. 2020;78:49-52
- 1 August 2020
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 80, 226
Response to: Deng L, Ma A, Wood N, Ardern-Holmes S. Vaccination management in an asymptomatic child with a novel SCN1A variant and family history of status epilepticus following vaccination: A case report on a potential new direction in personalised medicine. Seizure. 2020;78:49-52
- 1 January 2017
- Published by Elsevier in Epilepsy Research
- Vol. 129, 17-25
De novo and inherited SCN8A epilepsy mutations detected by gene panel analysis
- 1 January 2017
- Published by Elsevier in Epilepsy Research
- Vol. 129, 17-25
De novo and inherited SCN8A epilepsy mutations detected by gene panel analysis
- 13 September 2011
- Published by Wolters Kluwer Health in Neurology
- Vol. 77 (11) , 1055-1060
Massive expansion of SCA2 with autonomic dysfunction, retinitis pigmentosa, and infantile spasms
Objective: To provide clinical data on a cohort of 6 patients with massive expansion (>200 CAG repeats) of spinocerebellar ataxia type 2 (SCA2) and investigate possible pathways of pathogenesis using bioinformatics analysis of ATXN2 networks. Methods: We present data on 6 patients with massive expansion of SCA2 who presented in infancy with variable combinations of hypotonia, global developmental delay, infantile spasms, and retinitis pigmentosa. ATXN2 is known to interact with a network of synaptic proteins. To investigate pathways of pathogenesis, we performed bioinformatics analysis on ATXN2 combined with known genes associated with infantile spasms, retinitis pigmentosa, and synaptic function. Results: All patients had a progressive encephalopathy with autonomic dysfunction, 4 had retinitis pigmentosa, and 3 had infantile spasms. The bioinformatics analysis led to several interesting findings. First, an interaction between ATXN2 and SYNJ1 may account for the development of retinitis pigmentosa. Second, dysfunction of postsynaptic vesicle endocytosis may be important in children with this progressive encephalopathy. Infantile spasms may be associated with interactions between ATXN2 and the postsynaptic structural proteins MAGI2 and SPTAN1. Conclusions: Severe phenotype in children with massive expansion of SCA2 may be due to a functional deficit in protein networks in the postsynapse, specifically involving vesicle endocytosis.
- 13 September 2011
- Published by Wolters Kluwer Health in Neurology
- Vol. 77 (11) , 1055-1060
Massive expansion of SCA2 with autonomic dysfunction, retinitis pigmentosa, and infantile spasms
Objective: To provide clinical data on a cohort of 6 patients with massive expansion (>200 CAG repeats) of spinocerebellar ataxia type 2 (SCA2) and investigate possible pathways of pathogenesis using bioinformatics analysis of ATXN2 networks. Methods: We present data on 6 patients with massive expansion of SCA2 who presented in infancy with variable combinations of hypotonia, global developmental delay, infantile spasms, and retinitis pigmentosa. ATXN2 is known to interact with a network of synaptic proteins. To investigate pathways of pathogenesis, we performed bioinformatics analysis on ATXN2 combined with known genes associated with infantile spasms, retinitis pigmentosa, and synaptic function. Results: All patients had a progressive encephalopathy with autonomic dysfunction, 4 had retinitis pigmentosa, and 3 had infantile spasms. The bioinformatics analysis led to several interesting findings. First, an interaction between ATXN2 and SYNJ1 may account for the development of retinitis pigmentosa. Second, dysfunction of postsynaptic vesicle endocytosis may be important in children with this progressive encephalopathy. Infantile spasms may be associated with interactions between ATXN2 and the postsynaptic structural proteins MAGI2 and SPTAN1. Conclusions: Severe phenotype in children with massive expansion of SCA2 may be due to a functional deficit in protein networks in the postsynapse, specifically involving vesicle endocytosis.
- 1 December 2010
- Published by Elsevier in The Lancet Neurology
- Vol. 9 (12) , 1147-1148
Vaccination and Dravet syndrome.
- 1 December 2010
- Published by Elsevier in The Lancet Neurology
- Vol. 9 (12) , 1147-1148
Vaccination and Dravet syndrome.
Acquired Epileptiform Opercular Syndrome: A Second Case Report, Review of the Literature, and Comparison to the Landau‐Kleffner Syndrome
Summary: A 5‐year‐old girl developed recurrent prolonged episodes of severe oral apraxia, dysarthria, and drooling, similar to the opercular syndrome in children. Each episode lasted several weeks to >6 months and was associated with exacerbation of epileptiform activity in her EEG. Electrographic status epilepticus during slow wave sleep (ESES) was recorded during three of the exacerbations. The EEG improved markedly when clinical symptoms subsided. Antiepileptic drugs (AEDs) were not effective, although there was some improvement when they were combined with a ketogenic diet. A similar case was described by Roulet et al. We believe that this is a distinct epileptic syndrome, equivalent to the Landau‐Kleffner syndrome (LKS).
Acquired Epileptiform Opercular Syndrome: A Second Case Report, Review of the Literature, and Comparison to the Landau‐Kleffner Syndrome
Summary: A 5‐year‐old girl developed recurrent prolonged episodes of severe oral apraxia, dysarthria, and drooling, similar to the opercular syndrome in children. Each episode lasted several weeks to >6 months and was associated with exacerbation of epileptiform activity in her EEG. Electrographic status epilepticus during slow wave sleep (ESES) was recorded during three of the exacerbations. The EEG improved markedly when clinical symptoms subsided. Antiepileptic drugs (AEDs) were not effective, although there was some improvement when they were combined with a ketogenic diet. A similar case was described by Roulet et al. We believe that this is a distinct epileptic syndrome, equivalent to the Landau‐Kleffner syndrome (LKS).
- 31 July 1994
- Published by Elsevier in The Journal of Pediatrics
- Vol. 125 (1) , 174-175
Benign familial infantile epilepsy
- 31 July 1994
- Published by Elsevier in The Journal of Pediatrics
- Vol. 125 (1) , 174-175
Benign familial infantile epilepsy
- 1 February 1992
- Published by Elsevier in The Journal of Pediatrics
- Vol. 120 (2) , 266-269
Quadriplegia after chiropractic manipulation in an infant with congenital torticollis caused by a spinal cord astrocytoma
- 1 February 1992
- Published by Elsevier in The Journal of Pediatrics
- Vol. 120 (2) , 266-269
Quadriplegia after chiropractic manipulation in an infant with congenital torticollis caused by a spinal cord astrocytoma
- 1 October 1986
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 28 (5) , 646-648
Acute Dystonic Reaction to Bethanechol—a Direct Acetylcholine Receptor Agonist
Bethanechol is a direct agonist of the acetylcholine receptor that was recently introduced in the therapy of gastro-oesophageal reflux. Acute dystonic reactions to bethanechol were observed in a 10-month-old infant who also demonstrated similar dystonic reactions to dopamine receptor blocking agents of two different classes. This first report of acute dystonic reaction to cholinergic agonists in human is in accord with the current theories of the rôle of acetylcholine and dopamine in the pathogenesis of acute dystonic reactions.
- 1 October 1986
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 28 (5) , 646-648
Acute Dystonic Reaction to Bethanechol—a Direct Acetylcholine Receptor Agonist
Bethanechol is a direct agonist of the acetylcholine receptor that was recently introduced in the therapy of gastro-oesophageal reflux. Acute dystonic reactions to bethanechol were observed in a 10-month-old infant who also demonstrated similar dystonic reactions to dopamine receptor blocking agents of two different classes. This first report of acute dystonic reaction to cholinergic agonists in human is in accord with the current theories of the rôle of acetylcholine and dopamine in the pathogenesis of acute dystonic reactions.
- 2 March 1986
- Vol. 110 (5) , 237-8
[Acute dystonic reaction due to domperidone in a infant].
- 1 October 1985
- Published by Springer Nature in Pediatric Research
- Vol. 19 (10) , 1037-1039
Thyroid-Stimulating Hormone, Prolactin, and Growth Hormone Response to Thyrotropin-Releasing Hormone in Treated Children with Congenital Hypothyroidism
: The purpose of the present study was to assess thyroid-stimulating hormone (TSH), prolactin, and growth hormone responses to TRH stimulation in 12 congenitally hypothyroid children adequately treated with Lthyroxine from the first weeks of life. Although clinically euthyroid, six of these children were found to have abnormally high basal serum TSH concentrations despite clinical euthyroidism. Serum triiodothyroxine and L-thyroxine concentrations were normal and did not differ whether the children had elevated or normal basal serum TSH. All six of the children with high basal TSH had an exaggerated TSH response to TRH and 4 of them also had an augmented prolactin response to TRH. The children with normal basal TSH concentrations had normal TSH and prolactin responses to TRH. An abnormal (“paradoxical”) elevation of growth hormone concentration in response to TRH was found in four of seven children in a separate group of patients who had prolonged, untreated primary hypothyroidism, but such responses were not found in any of the adequately treated children. These findings suggest the following conclusions: 1) the phenomenon of high serum concentrations of TSH in conjunction with normal L-thyroxine and triiodothyronine levels (and clinical euthyroidism), is prevalent in congenital hypothyroid patients. 2) These patients have an exaggerated response of their pituitary thyrotroph and lactotroph cells to TRH, presumably caused by selective and relative resistance of these cells to the inhibitory effects of thyroid hormones. 3) Congenital hypothyroidism is not associated with abnormal somatotroph cell responses to TRH.
- 1 October 1985
- Published by Springer Nature in Pediatric Research
- Vol. 19 (10) , 1037-1039
Thyroid-Stimulating Hormone, Prolactin, and Growth Hormone Response to Thyrotropin-Releasing Hormone in Treated Children with Congenital Hypothyroidism
: The purpose of the present study was to assess thyroid-stimulating hormone (TSH), prolactin, and growth hormone responses to TRH stimulation in 12 congenitally hypothyroid children adequately treated with Lthyroxine from the first weeks of life. Although clinically euthyroid, six of these children were found to have abnormally high basal serum TSH concentrations despite clinical euthyroidism. Serum triiodothyroxine and L-thyroxine concentrations were normal and did not differ whether the children had elevated or normal basal serum TSH. All six of the children with high basal TSH had an exaggerated TSH response to TRH and 4 of them also had an augmented prolactin response to TRH. The children with normal basal TSH concentrations had normal TSH and prolactin responses to TRH. An abnormal (“paradoxical”) elevation of growth hormone concentration in response to TRH was found in four of seven children in a separate group of patients who had prolonged, untreated primary hypothyroidism, but such responses were not found in any of the adequately treated children. These findings suggest the following conclusions: 1) the phenomenon of high serum concentrations of TSH in conjunction with normal L-thyroxine and triiodothyronine levels (and clinical euthyroidism), is prevalent in congenital hypothyroid patients. 2) These patients have an exaggerated response of their pituitary thyrotroph and lactotroph cells to TRH, presumably caused by selective and relative resistance of these cells to the inhibitory effects of thyroid hormones. 3) Congenital hypothyroidism is not associated with abnormal somatotroph cell responses to TRH.